(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (20) | 6 (14) | 7 (6) | 8 (3) | 9 (4) | < (49) | A (334) | B (70) | C (269) | D (140) | E (194) | F (157) | G (461) | H (72) | I (178) | J (46) | K (71) | L (86) | M (209) | N (154) | O (62) | P (276) | Q (10) | R (114) | S (496) | T (559) | U (133) | V (38) | W (306) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | ‘ (2) | “ (1)
Title Last update
33-13.6 TB REACH Presentation Wed, 01/25/2023 - 05:19
33-2.1 Report of the Executive Director Wed, 01/25/2023 - 04:30
33-2.2 Stop TB Partnership KPI Results 2019_updated&final Wed, 01/25/2023 - 04:36
33-2.3 Stop TB Partnership preliminary KPI Results 2020 Wed, 01/25/2023 - 04:37
33-3.1 Targets - Stop TB Board Nov 2020 Wed, 01/25/2023 - 04:38
33-3.1 UNHLM_Targets&Commitments Wed, 01/25/2023 - 04:39
33-3.2 2020 UNSG Report on TB Wed, 01/25/2023 - 04:39
33-4.1 Global Plan – incl. resource needs for implementation and research Wed, 01/25/2023 - 04:40
33-4.2 UNHLM financing targets for countries Wed, 01/25/2023 - 04:41
33-4.4_FinancingTBresponse_BambooCapital Wed, 01/25/2023 - 04:42
33-4.6 Global Plan 2023-2030 development - STP Board Nov 2020 Wed, 01/25/2023 - 05:21
33-5.1 Covid PPT_Board Nov 2020 for LD Wed, 01/25/2023 - 04:54
33-5.2 Modelling study attention to TB during the Covid-19 pandemic Wed, 01/25/2023 - 04:54
33-5.3 Rapid information note on selection of SARS-CoV-2 diagnostics Wed, 01/25/2023 - 04:55
33-5.4 Information note on Digital Health technologies for TB during the Covid-19 pandemic Wed, 01/25/2023 - 04:55
33-6.1 STP UNHLM CRG Report_17 Nov 2020 Wed, 01/25/2023 - 04:56
33-6.2 The Impact of COVID on TB Response A Community Perspective Wed, 01/25/2023 - 04:57
33-9.1_GFcorporate_2020resultsreport_report_en Wed, 01/25/2023 - 04:59
33-9.2_GFcovid19_mitigatingimpact_report_en Wed, 01/25/2023 - 04:59
33-9.3_GFstrategydevelopment_2020openconsultationpdf_presentation_en Wed, 01/25/2023 - 04:59
33rd Stop TB Board Decision Points Wed, 01/25/2023 - 04:21
34-0.1_Virtual Guidance Note to the Board [.pdf] Wed, 01/18/2023 - 05:33
34-0.2_List of Documents [.pdf] Wed, 01/18/2023 - 05:34
34-0.3 List of Participants_draft 28 Sept [.pdf] Wed, 01/18/2023 - 05:35
34-1.1_Draft Board Agenda 20210926 [.pdf] Wed, 01/18/2023 - 05:49
34-1.2 Report on Actions of DPs_33rd Board Meeting [.pdf] Wed, 01/18/2023 - 05:49
34-1.3 Report of the Executive Director Wed, 01/18/2023 - 05:51
34-1.4_Stop TB Partnership KPI Results 2020 updated&final [.pdf] Wed, 01/18/2023 - 05:52
34-2.1_UNHLM Targets and Commitments GA [.pdf] Wed, 01/18/2023 - 05:53
34-2.2_UNHLM Targets and Commitments for 2022 [.pdf] Wed, 01/18/2023 - 05:59
34-3.1 A Deadly Divide TB Commitments Vs. TB Realities Tue, 01/24/2023 - 02:28
34-3.2_OneImpact CLM Conceptual and Implementation Framework FN Tue, 01/24/2023 - 02:29
34-3.3 Stop TB Stigma Assessment Tool Implementation Handbook Tue, 01/24/2023 - 02:29
34-3.4_Enabling TB Affected Community Engagement in TGF C19RM_Report on STP CS support package Tue, 01/24/2023 - 02:31
34-3.5_Communities, Rights and Gender_Progress and Achievements Presentation Tue, 01/24/2023 - 02:30
34-4.10_Forum on Microbial Threats Innovations for Tackling Tuberculosis in the time of covid-19 Tue, 01/24/2023 - 02:41